File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1136/bmjophth-2017-000100
- Scopus: eid_2-s2.0-85067422861
- WOS: WOS:000441775400003
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Development and pilot-testing of patient decision aid for use among Chinese patients with primary open-angle glaucoma
Title | Development and pilot-testing of patient decision aid for use among Chinese patients with primary open-angle glaucoma |
---|---|
Authors | |
Keywords | glaucoma public health |
Issue Date | 2017 |
Publisher | BMJ Group. The Journal's web site is located at http://bmjophth.bmj.com/ |
Citation | BMJ Open Ophthalmology, 2017 How to Cite? |
Abstract | Background: A patient decision aid (PDA) is a tool for shared decision making (SDM), which emphasises patient empowerment. It is useful in chronic diseases and when there are multiple, no best single treatment option. Although SDM is prevalent in Western countries, its use is limited in Chinese societies, where the adoption of a paternalistic approach is strong. Here, we report the development, acceptance and pilot test results of a PDA targeted at Chinese patients with primary open-angle glaucoma (POAG). Methods: We developed a PDA designed for use in Chinese patients with POAG. Recruited subjects were given our PDA. Baseline evaluation included decision conflict scale (DCS), validated glaucoma adherence questionnaires and glaucoma knowledge questionnaire. Subjects were briefed through the PDA and instructed to read it that day. Three to four weeks later, follow-up questionnaire as described above were conducted with the addition of acceptance questionnaires. Results: Data from 65 subjects were available. The PDA was well received among subjects. DCS improved from 48.9±20.4 at baseline to 34.3±20.3 during follow-up, with P<0.01. Validated medication adherence questionnaires and knowledge showed improvement from baseline, which was statistically significant. Conclusions: The use of PDA among Chinese subjects with POAG demonstrated positive reception and acceptance. Evaluation of its initial effects shows improvement in DCS, medication adherence and glaucoma knowledge. The implementation of SDM and PDA among Chinese subjects with POAG is encouraged. Future studies with randomised design and later evaluation time points can further reveal the impacts of PDA among Chinese subjects with POAG. |
Persistent Identifier | http://hdl.handle.net/10722/252738 |
ISSN | 2023 Impact Factor: 2.0 2023 SCImago Journal Rankings: 0.853 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shum, JWH | - |
dc.contributor.author | Lam, WWT | - |
dc.contributor.author | Choy, NKB | - |
dc.contributor.author | Chan, JCH | - |
dc.contributor.author | Ho, WL | - |
dc.contributor.author | Lai, JSM | - |
dc.date.accessioned | 2018-05-03T00:58:24Z | - |
dc.date.available | 2018-05-03T00:58:24Z | - |
dc.date.issued | 2017 | - |
dc.identifier.citation | BMJ Open Ophthalmology, 2017 | - |
dc.identifier.issn | 2397-3269 | - |
dc.identifier.uri | http://hdl.handle.net/10722/252738 | - |
dc.description.abstract | Background: A patient decision aid (PDA) is a tool for shared decision making (SDM), which emphasises patient empowerment. It is useful in chronic diseases and when there are multiple, no best single treatment option. Although SDM is prevalent in Western countries, its use is limited in Chinese societies, where the adoption of a paternalistic approach is strong. Here, we report the development, acceptance and pilot test results of a PDA targeted at Chinese patients with primary open-angle glaucoma (POAG). Methods: We developed a PDA designed for use in Chinese patients with POAG. Recruited subjects were given our PDA. Baseline evaluation included decision conflict scale (DCS), validated glaucoma adherence questionnaires and glaucoma knowledge questionnaire. Subjects were briefed through the PDA and instructed to read it that day. Three to four weeks later, follow-up questionnaire as described above were conducted with the addition of acceptance questionnaires. Results: Data from 65 subjects were available. The PDA was well received among subjects. DCS improved from 48.9±20.4 at baseline to 34.3±20.3 during follow-up, with P<0.01. Validated medication adherence questionnaires and knowledge showed improvement from baseline, which was statistically significant. Conclusions: The use of PDA among Chinese subjects with POAG demonstrated positive reception and acceptance. Evaluation of its initial effects shows improvement in DCS, medication adherence and glaucoma knowledge. The implementation of SDM and PDA among Chinese subjects with POAG is encouraged. Future studies with randomised design and later evaluation time points can further reveal the impacts of PDA among Chinese subjects with POAG. | - |
dc.language | eng | - |
dc.publisher | BMJ Group. The Journal's web site is located at http://bmjophth.bmj.com/ | - |
dc.relation.ispartof | BMJ Open Ophthalmology | - |
dc.rights | BMJ Open Ophthalmology. Copyright © BMJ Group. | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | glaucoma | - |
dc.subject | public health | - |
dc.title | Development and pilot-testing of patient decision aid for use among Chinese patients with primary open-angle glaucoma | - |
dc.type | Article | - |
dc.identifier.email | Lam, WWT: wwtlam@hku.hk | - |
dc.identifier.email | Choy, NKB: bnkchoy@hku.hk | - |
dc.identifier.email | Chan, JCH: jonochan@hku.hk | - |
dc.identifier.email | Ho, WL: hwl069@hku.hk | - |
dc.identifier.email | Lai, JSM: laism@hku.hk | - |
dc.identifier.authority | Shum, JWH=rp01849 | - |
dc.identifier.authority | Lam, WWT=rp00443 | - |
dc.identifier.authority | Choy, NKB=rp01795 | - |
dc.identifier.authority | Chan, JCH=rp02113 | - |
dc.identifier.authority | Lai, JSM=rp00295 | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.1136/bmjophth-2017-000100 | - |
dc.identifier.scopus | eid_2-s2.0-85067422861 | - |
dc.identifier.hkuros | 284922 | - |
dc.identifier.isi | WOS:000441775400003 | - |
dc.publisher.place | United Kingdom | - |
dc.identifier.issnl | 2397-3269 | - |